| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Biotest Aktiengesellschaft (XETRA: BIO3)
BIO3 Technical Analysis
3
| As on 6th Jun 2025 BIO3 STOCK Price closed @ 28.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 15.92 & Buy for SHORT-TERM with Stoploss of 27.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BIO3STOCK Price
| Open | 29.80 | Change | Price | % |
| High | 30.60 | 1 Day | -1.00 | -3.40 |
| Low | 28.40 | 1 Week | -1.60 | -5.33 |
| Close | 28.40 | 1 Month | -1.80 | -5.96 |
| Volume | 2403 | 1 Year | 1.70 | 6.37 |
| 52 Week High 30.50 | 52 Week Low 25.80 | ||||
XETRA Germany Most Active Stocks
| LHAR | 2.05 | -20.23% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BVBA | 0.02 | -60.00% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| AMMN | 8500.00 | 1440578.00% |
| TUI1 | 8.89 | % |
XETRA Germany Top Gainers Stocks
XETRA Germany Top Losers Stocks
| BIO3 Daily Charts |
BIO3 Intraday Charts |
Whats New @ Bazaartrend |
BIO3 Free Analysis |
|
|
BIO3 Important Levels Intraday
| RESISTANCE | 32.64 |
| RESISTANCE | 31.28 |
| RESISTANCE | 30.44 |
| RESISTANCE | 29.60 |
| SUPPORT | 27.20 |
| SUPPORT | 26.36 |
| SUPPORT | 25.52 |
| SUPPORT | 24.16 |
BIO3 Forecast February 2026
| 4th UP Forecast | 33.99 |
| 3rd UP Forecast | 32.2 |
| 2nd UP Forecast | 31.09 |
| 1st UP Forecast | 29.98 |
| 1st DOWN Forecast | 26.82 |
| 2nd DOWN Forecast | 25.71 |
| 3rd DOWN Forecast | 24.6 |
| 4th DOWN Forecast | 22.81 |
BIO3 Weekly Forecast
| 4th UP Forecast | 31.10 |
| 3rd UP Forecast | 30.23 |
| 2nd UP Forecast | 29.70 |
| 1st UP Forecast | 29.16 |
| 1st DOWN Forecast | 27.64 |
| 2nd DOWN Forecast | 27.10 |
| 3rd DOWN Forecast | 26.57 |
| 4th DOWN Forecast | 25.70 |
BIO3 Forecast2026
| 4th UP Forecast | 41.5 |
| 3rd UP Forecast | 37.3 |
| 2nd UP Forecast | 34.7 |
| 1st UP Forecast | 32.11 |
| 1st DOWN Forecast | 24.69 |
| 2nd DOWN Forecast | 22.1 |
| 3rd DOWN Forecast | 19.5 |
| 4th DOWN Forecast | 15.3 |
Biotest Aktiengesellschaft ( XETRA Germany Symbol : BIO3 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BIO3 Business Profile
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in haematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect for cytomegalovirus infections; Fovepta for hepatitis B prophylaxis in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and IgG Next Genration for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, as well as neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B re-infection prophylaxis after liver transplantation. In addition, it provides Albiomin and Biseko to restore and maintain circulating blood volume; Cofact for the treatment of clotting factors deficiency; Fibrinogen to treat congenital and acquired fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; Anti-SARS-CoV-2 hyperimmunoglobulin for COVID-19 treatment; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. Biotest Aktiengesellschaft was founded in 1946 and is headquartered in Dreieich, Germany. Address: Landsteinerstrasse 5, Dreieich, Germany, 63303
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service